Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley)
About Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley)
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to exceptional patient care, leading-edge research, and comprehensive educational programs in oncology. Founded in 1884, MSKCC has consistently been at the forefront of cancer treatment and discovery, integrating state-of-the-art scientific research with clinical investigation. For physicians, MSK offers a collaborative environment focused on advancing cancer care through innovative approaches, including targeted therapies, immunotherapy, and the strategic application of artificial intelligence (AI).
MSK is actively leveraging AI to accelerate research breakthroughs and improve clinical outcomes. This includes using AI for more precise diagnostics, early detection, and personalized treatment development by analyzing genomic, imaging, and clinical data. The institution has established an Enterprise AI Program with domains in research, clinical, and operations, supported by robust governance and infrastructure. MSK is also a founding member of the Cancer AI Alliance (CAIA), a collaborative research initiative with other leading cancer centers and technology powerhouses to accelerate the development and deployment of AI models in oncology.
While the prompt mentions a collaboration with UCSF and UC Berkeley, current information indicates that UCSF and UC Berkeley have launched their own joint program, the Bakar Computational Biomedicine Initiative, to advance AI in biomedicine and clinical care. This initiative focuses on developing computational tools and biomedical advances through expertise in computing, AI, statistics, biology, and medicine. Researchers from UC Berkeley and UCSF have also launched a startup, Voio, to build AI models for radiologists to interpret images faster and more accurately, and to predict patient risk for serious conditions like cancer.
Focus Areas
Business Intelligence
| Key Investors | The Starr Foundation, Pershing Square Philanthropies, National Science Foundation, David Geffen, Kenneth C. Griffin, John Jacob Astor III, John D. Rockefeller Jr., Alfred P. Sloan, Charles F. Kettering, David Koch, Stanley Druckenmiller, Orlando Bravo, Mort Zuckerman |
| Partnerships | UCSF, UC Berkeley (mentioned in prompt), Triomics, Amazon Web Services (AWS), Accenture, Avanade, Microsoft, PathPresenter, Blue Note Therapeutics, GNS Healthcare, Owkin, Moffitt Cancer Center, Huntsman Cancer Institute, Tisch Cancer Center of Mount Sinai Health System, Dana-Farber Cancer Institute, Fred Hutch Cancer Center, The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins, Ai2, Google, Nvidia, Slalom, Hartford HealthCare Cancer Institute, Hackensack Meridian Health |
| Acquisitions | Juno Therapeutics (MSK owned a small piece, acquired by Celgene for $9B in 2018), BlueRock Therapeutics (MSK licensed technology, acquired by Bayer in 2019) |
| Technology | cloud-native (Microsoft Azure Communications Services, AWS), AI operating system (collaborations for AI model development and deployment), digital pathology workflow software (PathPresenter integration), large language models (AWS) |
| FDA Clearances | 2 (CAR-T immunotherapy, MSK-IMPACT tumor identification test) cleared products (estimated) |
What Physicians Need to Know
For physicians, Memorial Sloan Kettering Cancer Center stands out due to its leadership in precision immuno-oncology and its extensive clinical trials program, offering access to cutting-edge treatments. The institution's robust digital pathology infrastructure and integration of AI tools can enhance diagnostic capabilities and research collaboration. MSK's comprehensive genetic counseling services can be a valuable resource for patients with a personal or family history of cancer. Additionally, their commitment to education and training provides numerous opportunities for professional development and collaboration in cancer research. Physicians can also leverage MSK's telemedicine options for second opinions and follow-up care for their patients.
Memorial Sloan Kettering Cancer Center has collaborated with UCSF and UC Berkeley. UCSF offers comprehensive cancer care, including specialized programs in areas like immunotherapy, cancer genetics, and older adult cancer care, with various support services. UC Berkeley's involvement typically focuses on research and academic collaborations, contributing to the broader scientific advancements in cancer. MSK's telemedicine platform integrates with Microsoft Teams and utilizes Microsoft Azure Communications Services for its virtual care delivery.
What the Web Says
Memorial Sloan Kettering Cancer Center (MSKCC) is widely recognized as a leading institution in cancer treatment and research, often praised for its specialized care and advanced medical approaches. While patient reviews highlight the expertise of their medical staff and positive outcomes, some mention long wait times for appointments. As an employer, MSKCC generally receives positive feedback for its culture, benefits, and opportunities for growth, though some employees report issues with management communication, workload, and compensation.
Overall: PositiveStrengths
- Leading expertise in cancer treatment and research.
- Advanced medical technologies and innovative treatments.
- Supportive and caring nursing staff.
- Good benefits and opportunities for career growth for employees.
- Collaborative and mission-driven work environment.
- Strong focus on patient care and positive patient outcomes.
Limitations
- Long wait times for appointments.
- Some employees report issues with management communication and support.
- Potential for low pay in certain positions.
- High workload and potential for unpaid overtime for some employees.
- Lack of diversity in clinical staff noted by some.
- Siloed departments and internal power struggles reported by some employees.
Based on reviews from: Indeed, Comparably, Reddit, Healthgrades, Memorial Sloan Kettering Cancer Center, SimplyHired, Handshake, Bookimed, InHerSight, ASCO Publications, ResearchGate, CDD Vault, iHirePublishing, InfoWorld, City & State New York
Last updated: 2026-08-06
Videos
News, demos, and interviews about Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley).
Videos load interactively. If none appear, search YouTube for Memorial Sloan Kettering Cancer Center (developed in collaboration with UCSF and UC Berkeley) →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]